Veracyte Announces Fourth Quarter and Full-Year 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall St declines as oil spikes after Trump rejects Iran peace proposal
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Bloom Energy shares fall on Oracle project halt
- Oppenheimer sees AI software winners as focus shifts to ROI
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
- Arm Holdings falls as CFO stock sale weighs on sentiment
Veracyte (VCYT) Misses Q4 EPS by 4c, Revenues Beat; Offers 1Q Revenues Guidance Above Consensus
February 17, 2021 4:29 PM ESTVeracyte (NASDAQ: VCYT) reported Q4 EPS of ($0.15), $0.04 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $34.5 million versus the consensus estimate of $31.93 million.
For the three months ended December 31, 2020, compared to the prior year:
Total Revenue was $34.5 million, an increase of 16%;Gross Margin was 68%, an increase of 2 percentage points;Operating Expenses, Excluding Cost of Revenue, were $31.4 million, an increase of... More